Loading results
In the News
powered by Ovast-
FDA Panel Mixed On Pfizer's Rare Disease Drug - FierceBiotech
google.com 3 days, 14 hours agoUpdated News FDA panel mixed on Pfizer's rare disease drug FierceBiotech Pfizer's pioneering rare-disease drug tafamidis garnered mixed reviews from FDA advisers Thursday, casting further uncertainty over whether the agency will green-light the treatment for the US market. Both the agency's advisers and staff have harped on ... US panel split on Pfizer rare disease drug FDA Panel Sends Mixed Message on Pfizer Drug FDA Reviewer Recommends Against Approval Of Pfizer Drug -
-
FDA Panel Votes Against Pfizer Rare Disease Drug
yahoo.com 3 days, 8 hours ago(Reuters) - Pfizer Inc said a U.S. health advisory panel voted against its drug to treat a rare neurodegenerative disease as the data did not show enough evidence of efficacy. The panel's recommendation will be considered by the U.S. Food and ...
Photos
powered by
Loading photos for 'Pfizer'
On Twitter
Loading tweets for 'Pfizer'
Videos
Loading videos for 'Pfizer'
Loading More Stories
